Top compounds associated with response to ADD3


Feature Type Standardized
Nominal ANOVA
mRNA tivantinib CTRPv2 pan-cancer AAC 0.031 0.5
mRNA tivozanib GDSC1000 pan-cancer AAC -0.031 0.4
mRNA tivozanib CTRPv2 pan-cancer AAC -0.015 0.7
mRNA tosedostat CTRPv2 pan-cancer AAC 0.016 0.7
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.062 0.09
mRNA tretinoin:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.028 0.4
mRNA triazolothiadiazine CTRPv2 pan-cancer AAC -0.033 0.3
mRNA trifluoperazine CTRPv2 pan-cancer AAC 0.062 0.1
mRNA triptolide CTRPv2 pan-cancer AAC -0.066 0.08
mRNA tubastatin A CTRPv2 pan-cancer AAC 0.11 0.04
Download CSV